4

PRIMARY DOCUMENT

Company: Eledon Pharmaceuticals, Inc.
Filed: May 22, 2019
Period of Report: May 20, 2019
Accession Number: 0001562180-19-003052

View Document ↗ View on SEC.gov ↗